Sirius Therapeutics
Sirius Therapeutics is developing transformative siRNA therapeutics for patients with chronic diseases globally. Founded in 2021, the company has established innovation and translational medicine centers focused on state-of-the-art solutions for chronic disease treatment and management. The company has three clinical-stage programs and a deep preclinical pipeline, focused on addressing cardiometabolic disorders.
Funding Round: Series B2
Funding Amount: $50M
Date: 09-May-2025
Investors: BioTrack Capital, OrbiMed, Creacion Ventures, Hankang Capital
Markets: Biotech, Therapeutics, Healthtech
HQ: San Diego, California, United States
Founded: 2021
Website: http://www.siriusrna.com/
Crunchbase: https://www.crunchbase.com/organization/sirius-therapeutics
Leave a Comment
Comments
No comments yet.